NEW YORK, Jan 4 - Informax said Thursday increased sales of Genomax and Vector NTI software would help to drive up fourth quarter revenues to $5.3 million while new bookings of $6.7 million in the quarter would generate strong revenues in the future.

In a conference call to discuss the company’s earnings outlook, CFO Joseph Lehnan said he expects “a very aggressive” 2001, predicting revenues of $32 million next year, almost double a projected $16.6 million for 2000. Informax said it was on track to achieve profitability by 2002.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.